Ryan Seacrest Foundation selects Cohen Children’s Medical Center as location for its newest Seacrest Studio

Cohen Children’s Medical Center was selected by the Ryan Seacrest Foundation (RSF) as the recipient of its newest Seacrest Studio, a state-of-the-art studio for pediatric patients to explore the creative realms of radio, television and new media. Cohen Children’s Medical Center will be home to the foundation’s 12th studio of this kind nationwide – and the only one in New York.

The studio, opening in 2022, will be located prominently in the atrium of Cohen Children’s Medical Center. Seacrest Studios are charitable endeavors of the Ryan Seacrest Foundation, founded by radio and television host and producer Ryan Seacrest along with his family. RSF hopes to contribute positively to the healing process for children and their families during their stay, as well as uplift spirits of the clinical and administrative staff at Cohen Children’s.

“The last two years have been unlike any other and I’m incredibly proud of the Ryan Seacrest Foundation for continuing to provide a creative outlet for patients and families during this difficult time,” said Ryan Seacrest. “I’m thrilled to announce our next location at New York’s Cohen Children’s Medical Center, which is near to my heart, in the city that I now call home. We’ve been fortunate to continue to grow and do the work we love, putting smiles on the faces of children and their families across the country and I can’t wait to cut the ribbon on this one in 2022.”

Seacrest made the announcement this morning on “LIVE with Kelly and Ryan,” the syndicated morning television talk show he co-hosts with Kelly Ripa.

Watch the announcement: https://www.northwell.edu/news/in-the-news/ryan-seacrest-studio-comes-to-cohen-children-039-s-medical-center

Seacrest Studios will be used to provide a variety of programming to patients, whether they are physically in the studio or watching through a closed-circuit network from their in-room television screen. Patients will have the opportunity to host their own radio and television shows, watch live musical performances, play games and even interview celebrity guests that visit. The studio will be encased in glass, allowing patients and visitors to view the daily programming happening inside.

“One of the primary goals for us at Cohen Children’s Medical Center is to continually improve and enhance the in-hospital experience, both for our patients and their families,” said Charles Schleien, MD, senior vice president and executive director of Cohen Children’s. “We are so grateful to the Ryan Seacrest Foundation for helping us provide an exciting new creative outlet at our hospital. The studio will be a great addition to our Child Life programs, all of which are designed to give our young patients the opportunity to play and relieve the stress of being in the hospital setting.”

Cohen Children’s Medical Center is the top-rated children’s hospital in New York State and has earned top national rankings for exceptional care in nine pediatric specialties, according to US News & World Report’s 2021-2022 Best Children’s Hospitals. As the largest provider of pediatric health care services in the state, Cohen Children’s has been ranked among the nation’s top children’s hospitals by US News for 15 consecutive years.

RSF has opened 11 other Seacrest Studios across the country: Atlanta, Boston, Charlotte, Cincinnati, Dallas, Denver, Nashville, Orange County, Orlando, Philadelphia and Washington, D.C.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

"Receiving this first FDA clearance for our retinal camera is not just a milestone, it's a leap forward in our quest to safeguard the vision of millions," said Dr. Patrick Sauvageau, optometrist, CEO, and co-founder of Zilia. "We're now focused on obtaining De Novo classification for ocular oximetry, a breakthrough biomarker that promises to revolutionize how we diagnose and manage a variety of ocular conditions."
The recent FDA clearances included Brainomix 360 e-CTP and Brainomix 360 e-MRI, both software modules that can support thrombolysis and thrombectomy treatment decisions, particularly for late-window patients who present to hospital more than 6-12 hours after stroke onset.
IONIC Health’s 510(k)-pending nCommand Lite technology is designed to include vendor-agnostic remote scanning capabilities. This strategic collaboration’s goal is to enable GE HealthCare to provide a multi-vendor, multi-modality remote scanning solution to healthcare systems and patients around the globe.
Silmitasertib works by inhibiting CK2 protein kinase, which have implicated in regulation of several signaling pathways that are important for innate immune responses. CK2 modulates inflammatory pathways, including NF-κB, PI3K–Akt–mTOR, and JAK–STAT.
"This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy